Pfizer quarterly results hit by soft demand for COVID-19 products

Pfizer on Tuesday reported its first quarterly loss since 2019 as demand for its COVID products dwindled. Sales of the company's coronavirus vaccine Comirnaty dropped 70% during the third quarter compared with the same period a year earlier. Sales of its COVID-19 treatment Paxlovid fell 97% from…#pfizer #marcsiegel #albertbourla #abrysvo #elrexfio #seageninc
Source: Reuters: Health - Category: Consumer Health News Source Type: news